MétaCan
Menu
← Back to cohort

Reply by Authors

2020· letter· en· W4230590552 on OpenAlexaboutno aff
Nima Almassi, Emily Vertosick, Chun Huang, Nathan C. Wong, Shawn Dason, Victor McPherson, Lucas Dean, Nicole Benfante, Daniel D. Sjoberg, Jonathan E. Rosenberg, Dean F. Bajorin, Harry W. Herr, Guido Dalbagni, Bernard H. Bochner

Bibliographic record

VenueThe Journal of Urology · 2020
Typeletter
Languageen
FieldMedicine
TopicBladder and Urothelial Cancer Treatments
Canadian institutionsnot available
Fundersnot available
KeywordsMedicine

Abstract

fetched live from OpenAlex

No AccessJournal of UrologyAdult Urology1 Oct 2020Reply by Authorsis a reply to letterEditorial CommentEditorial Comment Nima Almassi, Eugene K. Cha, Emily A. Vertosick, Chun Huang, Nathan Wong, Shawn Dason, Victor McPherson, Lucas Dean, Nicole Benfante, Daniel D. Sjoberg, Jonathan E. Rosenberg, Dean F. Bajorin, Harry W. Herr, Guido Dalbagni, and Bernard H. Bochner Nima AlmassiNima Almassi Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Recipient of National Institutes of Health T32 Ruth L. Kirschstein Institutional National Research Service Award. Equal study contribution. More articles by this author , Eugene K. ChaEugene K. Cha Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Equal study contribution. More articles by this author , Emily A. VertosickEmily A. Vertosick Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Chun HuangChun Huang Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Nathan WongNathan Wong Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Shawn DasonShawn Dason Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Current affiliation: Department of Urology, Ohio State University Comprehensive Cancer Center, Columbus, Ohio. More articles by this author , Victor McPhersonVictor McPherson Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Current affiliation: Division of Urology, McGill University, Montreal, Quebec, Canada. More articles by this author , Lucas DeanLucas Dean Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Current affiliation: Division of Urology, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada. More articles by this author , Nicole BenfanteNicole Benfante Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Daniel D. SjobergDaniel D. Sjoberg Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Jonathan E. RosenbergJonathan E. Rosenberg Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Financial interest and/or other relationship with Merck, Illumina, UpToDate, Bristol-Myers Squibb, AstraZeneca, Medscape, Vindico, Peerview, Chugai Pharma, Lilly, Agensys, Roche/Genentech, Sanofi, AstraZeneca/MedImmune, EMD Serono, Seattle Genetics, Bayer, Inovio Pharmaceuticals, BioClin Therapeutics, QED Therapeutic, Adicet Bio, Sensei Biotherapeutics, Genentech, Oncogenex, Mirati Therapeutics, Novartis, Viralytics and Incyte. More articles by this author , Dean F. BajorinDean F. Bajorin Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Financial interest and/or other relationship with Merck, Pfizer, Bristol-Myers Squibb, Urogen, Genentech and Eli Lilly. More articles by this author , Harry W. HerrHarry W. Herr Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Guido DalbagniGuido Dalbagni Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , and Bernard H. BochnerBernard H. Bochner ††Correspondence: Urology Service, Department of Surgery, Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 353 East 68th St., New York, New York 10065 telephone: 646-422-4387; FAX: 212-988-0759; E-mail Address: [email protected] Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Financial interest and/or other relationship with Olympus. More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001071.03AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Reply by Authors." The Journal of Urology, 204(4), p. 684 © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology23 Jul 2020Editorial CommentJournal of Urology23 Jul 2020Editorial Comment Volume 204Issue 4October 2020Page: 684-684 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Nima Almassi Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Recipient of National Institutes of Health T32 Ruth L. Kirschstein Institutional National Research Service Award. Equal study contribution. More articles by this author Eugene K. Cha Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Equal study contribution. More articles by this author Emily A. Vertosick Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Chun Huang Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Nathan Wong Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Shawn Dason Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Current affiliation: Department of Urology, Ohio State University Comprehensive Cancer Center, Columbus, Ohio. More articles by this author Victor McPherson Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Current affiliation: Division of Urology, McGill University, Montreal, Quebec, Canada. More articles by this author Lucas Dean Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Current affiliation: Division of Urology, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada. More articles by this author Nicole Benfante Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Daniel D. Sjoberg Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Jonathan E. Rosenberg Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Financial interest and/or other relationship with Merck, Illumina, UpToDate, Bristol-Myers Squibb, AstraZeneca, Medscape, Vindico, Peerview, Chugai Pharma, Lilly, Agensys, Roche/Genentech, Sanofi, AstraZeneca/MedImmune, EMD Serono, Seattle Genetics, Bayer, Inovio Pharmaceuticals, BioClin Therapeutics, QED Therapeutic, Adicet Bio, Sensei Biotherapeutics, Genentech, Oncogenex, Mirati Therapeutics, Novartis, Viralytics and Incyte. More articles by this author Dean F. Bajorin Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York Financial interest and/or other relationship with Merck, Pfizer, Bristol-Myers Squibb, Urogen, Genentech and Eli Lilly. More articles by this author Harry W. Herr Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Guido Dalbagni Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Bernard H. Bochner Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York ††Correspondence: Urology Service, Department of Surgery, Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 353 East 68th St., New York, New York 10065 telephone: 646-422-4387; FAX: 212-988-0759; E-mail Address: [email protected] Financial interest and/or other relationship with Olympus. More articles by this author Expand All Advertisement PDF downloadLoading ...

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.055
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Editorial · Consensus signal: none
Teacher disagreement score0.100
Threshold uncertainty score0.336

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.055
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0010.001
Science and technology studies0.0030.002
Scholarly communication0.0050.005
Open science0.0020.003
Research integrity0.0190.020
Insufficient payload (model declined to judge)0.1000.083

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.280
Teacher spread0.258 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEditorial

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueThe Journal of Urology→Same topicBladder and Urothelial Cancer Treatments→French-language works237,207→